《亞洲股市》港韓股續跌1%-1.1% 惟星馬臺股逆市續升0.3%-0.8%
阿思達克 11-08 09:32
美股上週五全面續升0.2%-0.6%齊創紀錄高，美國10月非農就業新增職位創三個月高兼勝預期，加上輝瑞(PFE.US)研發新冠口服藥臨牀試驗中期分析結果顯示能夠將住院和死亡風險大減八成九，刺激股價急漲近11%，反觀競爭對手默克(MRK.US)由紀錄高位急吐近9.9%爲最傷藍籌，但餘下近三分二藍籌造好，尤其是波音急彈逾5%，Travelers、陶氏、IBM、運通、迪士尼及Visa也依次升2%-3.8%，帶動道指曾漲363點，高見36,484再創紀錄高，收36,327，回升203點或近0.6%；美國兩大藥廠研發新冠口服藥測試療效顯着，美國三大航空及郵輪股升近6%-9%，季績及展望佳的高通(QCOM.US)續升4.4%曾高見168.55美元屢破頂，費城半導體指數升1.1%屢破頂，Meta及亞馬遜續升逾1%，Alphabet(GOOGL.US)曾高見3,006美元屢破頂，但奈飛由紀錄高位續吐3.4%，拖累納指及標普僅續升0.2%及近0.4%屢破頂。然而，美股期貨全面回吐約0.1%-0.3%。亞太區股市受壓，尤其是韓股續跌1.1%報2,935。
港股繼上週累跌506點及兩週累挫1,256點後，今早承上週五跌1.4%勢，在重磅新經濟股騰訊(00700.HK)/阿裏巴巴(09988.HK)低開1.6%-2.4%、友邦(01299.HK)及藥明生物(02269.HK)低開1%-3.8%、以及美團(03690.HK)低開0.8%主導，恆指低開126點或0.5%報24,743，在三大新經濟股沽壓增大，以及藥明生物跌幅擴至逾9%報92.45元，跌幅擴至236點或近1%報24,633。個股以擬於年底前關閉300家門店的海底撈(06862.HK)表現最好，股價逆市續彈8.5%曾高見23.3元。
以美元計價的內地10月出口額按年升幅收窄至27.1%，優於市場預期升23%；進口額按年升幅加快至20.6%，遜於市場預期升25%。滬深股市連跌兩週後，上證及深成繼上週五分別回吐1%及0.6%勢，現報3,487及14,452，續跌約0.1%。
然而，新加坡海峽時報指數續升0.8%報3,269。吉隆坡綜合指數升0.3%報1,536。臺灣加權指數續升0.3%報17,342。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
More Content
CS Hotline: +852 3018 4526
Trading days: 24 hours | Non-trading days: 9:00-18:00
